Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Acrivon Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +22 vs. Q4 2022
- Shares held
- 15.2M
- +534.7K (+3.6%) vs. Q4 2022
- Total value
- $191.1M
- +$24.0M (+14.3%) vs. Q4 2022
- New holders
- 25
- 6 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,810,508 | $61.0M | 1.38% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $38.2M | 1.13% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 1,652,605 | $21.0M | 5.18% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,641,022 | $20.1M | 0.02% | +6,918+0.4% | Added |
| Wellington Management Group LLP | 888,130 | $11.1M | 0.00% | −12,019−1.3% | Reduced |
| Federated Hermes, Inc. | 613,625 | $7.79M | 0.02% | −209,675−25.5% | Reduced |
| Marshall Wace, LLP | 597,469 | $7.58M | 0.02% | −625,783−51.2% | Reduced |
| BlackRock Inc. | 474,227 | $6.02M | 0.00% | +474,227 | New |
| Vanguard Group Inc | 409,215 | $5.19M | 0.00% | +409,215 | New |
| NEA Management Company, LLC | 481,677 | $4.89M | 0.34% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 175,404 | $2.23M | 0.00% | +175,404 | New |
| State Street Corp | 85,339 | $1.08M | 0.00% | +85,339 | New |
| Northern Trust Corp | 69,751 | $885.1K | 0.00% | +69,751 | New |
| D. E. Shaw & Co., Inc. | 61,896 | $785.5K | 0.00% | +61,896 | New |
| Charles Schwab Investment Management Inc | 58,209 | $738.7K | 0.00% | +58,209 | New |
| DAFNA Capital Management LLC | 51,148 | $649.1K | 0.19% | +35,500+226.9% | Added |
| Susquehanna International Group, LLP | 32,262 | $409.4K | 0.00% | +32,262 | New |
| Bank of New York Mellon Corp | 22,837 | $289.8K | 0.00% | +22,837 | New |
| Barclays PLC | 16,983 | $215.5K | 0.00% | +12,841+310.0% | Added |
| Goldman Sachs Group Inc | 13,718 | $174.1K | 0.00% | −25,082−64.6% | Reduced |
| JPMorgan Chase & Co | 6,630 | $84.0K | 0.00% | +6,630 | New |
| Bank of America Corp | 5,856 | $74.3K | 0.00% | +5,856 | New |
| Morgan Stanley | 5,624 | $71.4K | 0.00% | +4,755+547.2% | Added |
| UBS Group AG | 5,396 | $68.5K | 0.00% | +648+13.6% | Added |
| Deutsche Bank AG | 5,369 | $68.1K | 0.00% | +5,369 | New |
| MetLife Investment Management | 5,081 | $64.5K | 0.00% | +5,081 | New |
| American International Group, Inc. | 4,178 | $53.0K | 0.00% | +4,178 | New |
| California State Teachers Retirement System | 3,218 | $40.8K | 0.00% | +3,218 | New |
| New York State Common Retirement Fund | 2,206 | $28.0K | 0.00% | +2,206 | New |
| STRS Ohio | 1,800 | $22.0K | 0.00% | +1,800 | New |
| Wells Fargo & Company | 1,588 | $20.2K | 0.00% | +1,588 | New |
| Tower Research Capital LLC (TRC) | 1,092 | $14.0K | 0.00% | +933+586.8% | Added |
| Amalgamated Bank | 1,130 | $14.0K | 0.00% | +1,130 | New |
| Legal & General Group Plc | 924 | $11.7K | 0.00% | +924 | New |
| Ameritas Investment Partners, Inc. | 695 | $8.82K | 0.00% | +695 | New |
| Royal Bank of Canada | 665 | $8.00K | 0.00% | +665 | New |
| Metropolitan Life Insurance Co | 523 | $6.64K | 0.00% | +523 | New |
| Citigroup Inc | 202 | $2.56K | 0.00% | +202 | New |
| FMR LLC | 122 | $1.55K | 0.00% | +122 | New |
| Bank of Montreal | 0 | $0 | 0.00% | −42,444−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,534−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,639−100.0% | Sold out |
| HealthCor Management, L.P. | – | – | – | – | Not filed |